Controlled delivery of IL-10 and retinoic acid for the treatment of psoriasis using a multilayered microneedle
RSC Pharmaceutics · 2026 · 3 (4) · 955-968
DOI: 10.1039/d5pm00233h ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Nathaniel Wright und 8 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: National Science Foundation, Cornell University.
Abstract (Originalsprache)
Here we report a novel immunotherapeutic system capable of localized targeting with time dependent release of small and biological molecules. This is the first coacervate microneedle combination product.
Förderung
- National Science Foundation
- Cornell University
Zitieren
APA
Wright, N., Bhashyam, P., Seo, L., Wu, T., McGurk, A. I., Ocasio-Rivera, M., D'Amato, A. R., Fowell, D. J., & Wang, Y. (2026). Controlled delivery of IL-10 and retinoic acid for the treatment of psoriasis using a multilayered microneedle. RSC Pharmaceutics, 3(4), 955-968. https://doi.org/10.1039/d5pm00233h
Vancouver
Wright N, Bhashyam P, Seo L, Wu T, McGurk AI, Ocasio-Rivera M, et al. Controlled delivery of IL-10 and retinoic acid for the treatment of psoriasis using a multilayered microneedle. RSC Pharmaceutics. 2026;3(4):955-968. doi:10.1039/d5pm00233h
BibTeX
@article{Wright2026,
author = {Wright, Nathaniel and Bhashyam, Priya and Seo, Lea and Wu, Tim and McGurk, Alexander I. and Ocasio-Rivera, Marinel and D'Amato, Anthony R. and Fowell, Deborah J. and Wang, Yadong},
title = {Controlled delivery of IL-10 and retinoic acid for the treatment of psoriasis using a multilayered microneedle},
journal = {RSC Pharmaceutics},
year = {2026},
volume = {3},
number = {4},
pages = {955--968},
doi = {10.1039/d5pm00233h}
}
EUVIMED